Table 1.

Genetic variants associated with NAFLD.

Gene	Effect on NAFLD/NASH
Palatine like phospholipase domain containing 3 (PNPLA-3) [15,16,17]	Increased risk of hepatic steatosis, incidence of NASH and severity of fibrosis
Farnesyl diphosphate farnesyl transferase I (FDFT1) [19]	Increased severity of NAFLD activity score
Collagen type XIII alpha 1 (COL13A1) [19]	Increased severity of fibrosis
Neurocan (NCAN) [19]	Increased risk hepatic steatosis
Glucokinase regulatory protein (GCKR) [19]	Increased risk hepatic steatosis
Transmembrane 5 superfamily member 2 (TM6SF2) [21]	Increased risk for hepatic fibrosis